Wednesday, July 9, 2025

Perimeter & Intermountain Study OCT, AI in Cancer Care

Related stories

Warmwind OS: Is It the Next-Generation Platform for Edge and IoT?

Edge operating systems are now important in the realm...

ClickUp Launches Brain MAX, the App Built to End AI Sprawl and Transform

ClickUp, the leading all-in-one productivity platform, announced the launch...

Rackspace Technology announced the launch of Rackspace OpenStack Business

Rackspace Technology, a leading provider of end-to-end hybrid cloud...

Coralogix Partners with AWS to Advance AI Observability and Security

Coralogix, a leading full-stack observability platform, announced a Strategic...

Allyant Announces the Launch of its AI-Powered PDF Remediation Software

Allyant, the leader in accessible document, digital and print...
spot_imgspot_img

Perimeter Medical Imaging AI, Inc., a commercial-stage medical technology company, is pleased to announce that it has entered into a Development Support Agreement (“DSA”) with Salt Lake City-based Intermountain Health, the largest nonprofit health system in the Intermountain West. This agreement creates the framework for the two organizations to partner on a number of future studies evaluating the potential value of using Perimeter’s OCT and collecting additional data to support the continued development of the Company’s artificial intelligence (“AI”) algorithms.

In the first of these studies, Intermountain Health will support a retrospective analysis of population level reoperation rates and incremental healthcare costs associated with reoperation for patients who underwent initial breast-conserving surgery (“BCS”) at select hospital sites.

Also Read: Kenvue & Microsoft partner to transform digital operations

“At Intermountain Health, we understand the significance of innovation, like Perimeter’s proprietary wide-field OCT interoperative margin assessment technology, that has the potential to optimize surgical oncology outcomes for patients, and support efficient delivery of care,” said Teresa Reading, MD, medical director, breast surgery, Canyons Region at Intermountain Health who is involved with the clinical use of this technology. “We look forward to initiating this first study among our BCS patient population, as well as potentially expanding to other tissue types in the future.”

“Intermountain Health is a fully integrated healthcare delivery system. It shares our commitment to improving both the patient and provider experience through innovation. And with its own health plan, Intermountain Health is uniquely positioned to evaluate the total cost of cancer reoperations – not only to the patient, but also to the payer,” commented Adrian Mendes, Perimeter’s Chief Executive Officer. “We are excited about how this partnership can help shape our commercial and market access strategies as we work to advance not only our next-generation, AI-enabled Perimeter OCT system for use during BCS through the FDA PMA approval process, but also as we look to expand into other tissue types beyond breast.”

Source: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img